Piscaglia F.; Stefanini F.; Cantisani V.; Sidhu P.S.; Barr R.; Berzigotti A.; Chammas M.C.; Correas J.-M.; Dietrich C.F.; Feinstein S.; Huang P.; Jenssen C.; Jenssen C.; Kono Y.; Kudo M.; Liang P.; Lyshchik A.; Nolsoe C.; Xie X.; Tovoli F., Benefits, Open questions and Challenges of the use of Ultrasound in the COVID-19 pandemic eraThe views of a panel of worldwide international experts, «ULTRASCHALL IN DER MEDIZIN», 2020, 41, pp. 228 - 236 [Scientific article]
Orsi G.; Tovoli F.; Dadduzio V.; Vivaldi C.; Brunetti O.; Ielasi L.; Conti F.; Rovesti G.; Gramantieri L.; Rizzato M.D.; Pecora I.; Argentiero A.; Teglia F.; Lonardi S.; Salani F.; Granito A.; Zagonel V.; Marisi G.; Cabibbo G.; Foschi F.G.; Benevento F.; Cucchetti A.; Piscaglia F.; Cascinu S.; Scartozzi M.; Casadei-Gardini A., Correction to: Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma (Targeted Oncology, (2020), 15, 6, (773-785), 10.1007/s11523-020-00757-3), «TARGETED ONCOLOGY», 2020, 15, pp. 809 - 810 [Scientific article]
Yau T.; Kang Y.-K.; Kim T.-Y.; El-Khoueiry A.B.; Santoro A.; Sangro B.; Melero I.; Kudo M.; Hou M.-M.; Matilla A.; Tovoli F.; Knox J.J.; Ruth He A.; El-Rayes B.F.; Acosta-Rivera M.; Lim H.-Y.; Neely J.; Shen Y.; Wisniewski T.; Anderson J.; Hsu C., Efficacy and Safety of Nivolumab plus Ipilimumab in Patients with Advanced Hepatocellular Carcinoma Previously Treated with Sorafenib: The CheckMate 040 Randomized Clinical Trial, «JAMA ONCOLOGY», 2020, 11, pp. 1 - 8 [Scientific article]Open Access
Tovoli F.; Ferri S.; Piscaglia F., Hepatocellular carcinoma in non alcoholic fatty liver disease, «CURRENT PHARMACEUTICAL DESIGN», 2020, 26, pp. 3909 - 3914 [Scientific article]
Renzulli M.; Clemente A.; Ierardi A.M.; Pettinari I.; Tovoli F.; Brocchi S.; Peta G.; Cappabianca S.; Carrafiello G.; Golfieri R., Imaging of colorectal liver metastases: New developments and pending issues, «CANCERS», 2020, 12, Article number: 151 , pp. 1 - 11 [Scientific article]Open Access
Tovoli F.; De Lorenzo S.; Trevisani F., Immunotherapy with checkpoint inhibitors for hepatocellular carcinoma: Where are we now?, «VACCINES», 2020, 8, Article number: 578 , pp. 1 - 21 [Scientific article]Open Access
Elisabetta Goio; Luca Ielasi; Francesca Benevento; Matteo Renzulli; Francesco Tovoli, Long-lasting remission in a metastatic hepatocellular carcinoma patient after combined regorafenib therapy and surgery, «HEPATIC ONCOLOGY», 2020, 7, Article number: HEP24 , pp. 1 - 6 [Scientific article]Open Access
De Lorenzo S.; Tovoli F.; Mazzotta A.; Vasuri F.; Edeline J.; Malvi D.; Boudjema K.; Renzulli M.; Jeddou H.; D'errico A.; Turlin B.; Cescon M.; Uguen T.; Granito A.; Lievre A.; Brandi G., Non-alcoholic steatohepatitis as a risk factor for intrahepatic cholangiocarcinoma and its prognostic role, «CANCERS», 2020, 12, Article number: 3182 , pp. 1 - 14 [Scientific article]Open Access
Orsi G.; Tovoli F.; Dadduzio V.; Vivaldi C.; Brunetti O.; Ielasi L.; Conti F.; Rovesti G.; Gramantieri L.; Rizzato M.D.; Pecora I.; Argentiero A.; Teglia F.; Lonardi S.; Salani F.; Granito A.; Zagonel V.; Marisi G.; Cabibbo G.; Foschi F.G.; Benevento F.; Cucchetti A.; Piscaglia F.; Cascinu S.; Scartozzi M.; Casadei-Gardini A., Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma, «TARGETED ONCOLOGY», 2020, 15, pp. 773 - 785 [Scientific article]
Tovoli F.; Guerra P.; Iavarone M.; Veronese L.; Renzulli M.; De Lorenzo S.; Benevento F.; Brandi G.; Stefanini F.; Piscaglia F., Surveillance for Hepatocellular Carcinoma Also Improves Survival of Incidentally Detected Intrahepatic Cholangiocarcinoma Arisen in Liver Cirrhosis, «LIVER CANCER», 2020, 11, pp. 1 - 12 [Scientific article]Open Access
Sansone V.; Le Grazie M.; Roselli J.; Polvani S.; Galli A.; Tovoli F.; Tarocchi M., Telomerase reactivation is associated with hepatobiliary and pancreatic cancers, «HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL», 2020, 19, pp. 420 - 428 [Scientific article]
Francesco Caputo,Vincenzo Dadduzio,Francesco Tovoli,Giulia Bertolini,Giuseppe Cabibbo,Krisida Cerma,Caterina Vivaldi,Luca Faloppi,Mario Domenico Rizzato,Fabio Piscaglia,Ciro Celsa,Lorenzo Fornaro,Giorgia Marisi,Fabio Conti,Nicola Silvestris,Marianna Silletta,Sara Lonardi,Alessandro Granito,Caterina Stornello,Valentina Massa,Giorgio Astara,Sabina Delcuratolo,Stefano Cascinu,Mario Scartozzi,Andrea Casadei-Gardini, The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib, «PLOS ONE», 2020, 15, Article number: e0232449 , pp. 1 - 13 [Scientific article]Open Access
Leoni S.; Sansone V.; De Lorenzo S.; Ielasi L.; Tovoli F.; Renzulli M.; Golfieri R.; Spinelli D.; Piscaglia F., Treatment of combined hepatocellular and cholangiocarcinoma, «CANCERS», 2020, 12, Article number: 794 , pp. 794 - 809 [Scientific article]Open Access
Brandi G.; Rizzo A.; Deserti M.; Relli V.; Indio V.; Bin S.; Pariali M.; Palloni A.; De Lorenzo S.; Tovoli F.; Tavolari S., Wilson disease, ABCC2 c.3972C > T polymorphism and primary liver cancers: suggestions from a familial cluster, «BMC MEDICAL GENETICS», 2020, 21, Article number: 225 , pp. 225 - 230 [Scientific article]Open Access
Renzulli M.; Clemente A.; Tovoli F.; Cappabianca S.; Bolondi L.; Golfieri R., Hepatocellular adenoma: An unsolved diagnostic enigma, «WORLD JOURNAL OF GASTROENTEROLOGY», 2019, 25, pp. 2442 - 2449 [Scientific article]Open Access
